Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance

L Taddia, D D'Arca, S Ferrari, C Marraccini… - Drug Resistance …, 2015 - Elsevier
Our current understanding of the mechanisms of action of antitumor agents and the precise
mechanisms underlying drug resistance is that these two processes are directly linked …

Peptides for diagnosis and treatment of ovarian cancer

L Guo, J Wang, N Li, J Cui, Y Su - Frontiers in oncology, 2023 - frontiersin.org
Ovarian cancer is the most deadly gynecologic malignancy, and its incidence is gradually
increasing. Despite improvements after treatment, the results are unsatisfactory and survival …

Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer

J Chen, Z Wang, S Gao, K Wu, F Bai, Q Zhang… - Cancer Cell …, 2021 - Springer
Aim Pemetrexed, a new generation antifolate drug, has been approved for the treatment of
locally advanced or metastatic breast cancer. However, factors affecting its efficacy and …

Folic Acid–Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting

G Marverti, C Marraccini, A Martello… - Journal of medicinal …, 2021 - ACS Publications
Drug–target interaction, cellular internalization, and target engagement should be
addressed to design a lead with high chances of success in further optimization stages …

Enhanced anticancer effect of thymidylate synthase dimer disrupters by promoting intracellular accumulation

G Marverti, MG Moschella, A Belardo… - Frontiers in …, 2024 - frontiersin.org
Introduction Thymidylate synthase (TS) plays a crucial role in cellular growth, proliferation,
DNA synthesis, and repair, thus gaining attention for targeted therapies in cancer. TS …

Pemetrexed ameliorates Con A-induced hepatic injury by restricting M1 macrophage activation

Z Liu, Z Bao, B Yu, L Chen, G Yang - International Immunopharmacology, 2023 - Elsevier
Autoimmune hepatitis (AIH), characterized by immune-driven liver destruction and cytokine
production, is a progressive inflammatory liver condition that may progress to hepatic …

Human thymidylate synthase inhibitors halting ovarian cancer growth

S Ferrari, L Severi, C Pozzi, A Quotadamo… - Vitamins and …, 2018 - Elsevier
Human thymidylate synthase (hTS) has an important role in DNA biosynthesis, thus it is
essential for cell survival. TS is involved in the folate pathways, specifically in the de novo …

pH-promoted release of a novel anti-tumour peptide by “stealth” liposomes: Effect of nanocarriers on the drug activity in cis-platinum resistant cancer cells

F Sacchetti, G Marverti, D D'Arca, L Severi… - Pharmaceutical …, 2018 - Springer
Purpose To evaluate the potential effects of PEGylated pH-sensitive liposomes on the
intracellular activity of a new peptide recently characterized as a novel inhibitor of the human …

Enhanced anti-hyperproliferative activity of human thymidylate synthase inhibitor peptide by solid lipid nanoparticle delivery

F Sacchetti, C Marraccini, D D'Arca, M Pelà… - Colloids and Surfaces B …, 2015 - Elsevier
Abstract Recently, octapeptide LSCQLYQR (LRp), reducing growth of cis-platinum (cDDP)
resistant ovarian carcinoma cells by inhibiting the monomer–monomer interface of the …

[HTML][HTML] Peptidome characterization of ovarian cancer serum and the identification of tumor suppressive peptide ZYX36-58

X Wang, G Liu, N Sheng, M Zhang, X Pan… - Annals of …, 2020 - ncbi.nlm.nih.gov
Background Several serum biomarkers, including miRNA, mRNA, protein and peptides in
cancer patients are also important mediators of cancer progression. Methods The …